Swiss biotech Stalicla hopes to bring precision medicine to autism. Experts praise efforts to identify autism subgroups, but evidence to support the company’s claims has yet to be seen.
Spectrum: Autism Research News
In this edition, researchers sink a purported link between cerebellar volume and autism and buoy a theory about measuring social behaviors.
The investigational drug arbaclofen makes autistic people’s brains respond to a visual task more like non-autistic people’s brains do.
Scientists should heed these differences when considering resting-state brain activity as a biomarker for autism, the researchers say.
Preliminary results suggested the treatment is no better than placebo at reducing the severity of core autism traits.
Brain responses to visual stimuli are smaller and weaker in children with Phelan-McDermid syndrome, an autism-linked genetic condition, than in non-autistic children.
Integrating genetic analyses into studies of babies’ brain development could help us understand how autism-related genes contribute to autism traits.